Home

Yu-Waye Chu, Chief Medical Officer: Fate Therapeutics FATE Sell · Filed 23/04/19

Trade details

Type
Insider sale
Amount
$1,401.8
Shares · price
215 sh · $6.52 a share
Held after
142,993 sh
Trade date
23/04/18
Filed
23/04/19
Days to filing
1 days

Sold 0.2% of holdings

Share of holding sold
0.2%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/19~23/05/18

Yu-Waye Chu's recent trades

  • Yu-Waye Chu

    SellCytomX Therapeutics

    $136.6K

    Filed 03/19

  • Yu-Waye Chu

    SellCytomX Therapeutics

    $2,415

    Filed 25/03/20

  • Yu-Waye Chu

    Sell10b5-1 planFate Therapeutics

    $15.2K

    Filed 23/04/19

  • Yu-Waye Chu

    SellFate Therapeutics

    $41K

    Filed 23/01/11